Turan A, Tarique M, Zhang L, Kazmi S, Ulker V, Tedla M
J Immunol. 2024; 212(12):1971-1980.
PMID: 38709159
PMC: 11160431.
DOI: 10.4049/jimmunol.2300743.
Turan A, Zhang L, Tarique M, Ulker V, Arguc F, Badal D
Am J Transplant. 2023; 23(5):619-628.
PMID: 36863480
PMC: 10318623.
DOI: 10.1016/j.ajt.2023.02.021.
Shrestha P, Turan A, Batra L, Gulen A, Sun Z, Tan H
Blood Adv. 2023; 7(10):2181-2195.
PMID: 36780582
PMC: 10196989.
DOI: 10.1182/bloodadvances.2022008495.
Lei J, Coronel M, Yolcu E, Deng H, Grimany-Nuno O, Hunckler M
Sci Adv. 2022; 8(19):eabm9881.
PMID: 35559682
PMC: 9106299.
DOI: 10.1126/sciadv.abm9881.
Risso V, Lafont E, Le Gallo M
Cell Death Dis. 2022; 13(3):248.
PMID: 35301281
PMC: 8931059.
DOI: 10.1038/s41419-022-04688-x.
Local delivery strategies to restore immune homeostasis in the context of inflammation.
Bentley E, Little S
Adv Drug Deliv Rev. 2021; 178:113971.
PMID: 34530013
PMC: 8556365.
DOI: 10.1016/j.addr.2021.113971.
Local Immunomodulatory Strategies to Prevent Allo-Rejection in Transplantation of Insulin-Producing Cells.
Wang X, Brown N, Wang B, Shariati K, Wang K, Fuchs S
Adv Sci (Weinh). 2021; 8(17):e2003708.
PMID: 34258870
PMC: 8425879.
DOI: 10.1002/advs.202003708.
Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival.
Coronel M, Martin K, Hunckler M, Barber G, ONeill E, Medina J
Sci Adv. 2020; 6(35):eaba5573.
PMID: 32923626
PMC: 7455180.
DOI: 10.1126/sciadv.aba5573.
Adenovirus-Mediated Minigene Transfer Endows Transduced Cells with Killer Potential.
Dumitrescu M, Trusca V, Savu L, Stancu I, Ratiu A, Simionescu M
Int J Mol Sci. 2020; 21(17).
PMID: 32825521
PMC: 7504687.
DOI: 10.3390/ijms21176011.
Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.
Batra L, Shrestha P, Zhao H, Woodward K, Togay A, Tan M
J Immunol. 2020; 204(10):2840-2851.
PMID: 32253240
PMC: 7334868.
DOI: 10.4049/jimmunol.2000055.
Nanotechnology Approaches to Modulate Immune Responses to Cell-based Therapies for Type 1 Diabetes.
Wiggins S, Abuid N, Gattas-Asfura K, Kar S, Stabler C
J Diabetes Sci Technol. 2020; 14(2):212-225.
PMID: 32116026
PMC: 7196865.
DOI: 10.1177/1932296819871947.
Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.
Woodward K, Zhao H, Shrestha P, Batra L, Tan M, Grimany-Nuno O
Am J Transplant. 2019; 20(5):1285-1295.
PMID: 31850658
PMC: 7299172.
DOI: 10.1111/ajt.15747.
Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide Tethers.
Yerneni S, Lathwal S, Shrestha P, Shirwan H, Matyjaszewski K, Weiss L
ACS Nano. 2019; 13(9):10555-10565.
PMID: 31436946
PMC: 6800810.
DOI: 10.1021/acsnano.9b04651.
A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4 T and Natural Killer Cells.
Barsoumian H, Batra L, Shrestha P, Bowen W, Zhao H, Egilmez N
Cancer Res. 2019; 79(4):783-794.
PMID: 30770367
PMC: 6450554.
DOI: 10.1158/0008-5472.CAN-18-2401.
Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance.
Headen D, Woodward K, Coronel M, Shrestha P, Weaver J, Zhao H
Nat Mater. 2018; 17(8):732-739.
PMID: 29867165
PMC: 6060019.
DOI: 10.1038/s41563-018-0099-0.
An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8 T Cells.
Wang W, Shahzad K, Li M, Zhang A, Zhang L, Xu T
Front Immunol. 2017; 8:657.
PMID: 28649247
PMC: 5465244.
DOI: 10.3389/fimmu.2017.00657.
Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective.
Yolcu E, Shirwan H, Askenasy N
Stem Cells Transl Med. 2017; 6(3):700-712.
PMID: 28186688
PMC: 5442770.
DOI: 10.1002/sctm.16-0358.
Strategies for cell membrane functionalization.
Armstrong J, Perriman A
Exp Biol Med (Maywood). 2016; 241(10):1098-106.
PMID: 27229904
PMC: 4950370.
DOI: 10.1177/1535370216650291.
Immune Tolerance for Autoimmune Disease and Cell Transplantation.
Luo X, Miller S, Shea L
Annu Rev Biomed Eng. 2016; 18:181-205.
PMID: 26928211
PMC: 4947009.
DOI: 10.1146/annurev-bioeng-110315-020137.
A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo.
Wang W, Fang K, Li M, Chang D, Shahzad K, Xu T
Oncotarget. 2016; 7(11):12176-90.
PMID: 26910923
PMC: 4914277.
DOI: 10.18632/oncotarget.7519.